许多人被召,少数人被拣选:科学在药物开发决策中的作用
Linde Colen1, René Belderbos2,3,4, Stijn Kelchtermans1,2
1Hasselt University, Hasselt, Belgium.
概括
制药公司优先考虑具有强大的科学基础的候选药物. 公司内部的研究促进了开发成功和公司内部的采用,强调了综合药物设计的价值.
科学领域:
- 制药科学 制药科学
- 生物技术是生物技术.
- 药物发现 药物发现 药物发现
背景情况:
- 制药公司在药物开发中面临高昂的成本和风险,导致候选药物的选择性进展.
- 研究候选药物的科学基础和起源影响其进入临床试验的进展.
研究的目的:
- 调查科学研究对专利药物候选药物的临床研发采用的影响.
- 确定科学研究的来源 (内部与外部) 是否会影响内部与外部的采用和开发成功.
主要方法:
- 分析了136家制药公司专利的18360种候选药物.
- 统计检查科学参考,研究来源和临床开发采用之间的关系.
主要成果:
- 引用科学研究的专利候选药物更有可能进入开发阶段.
- 公司内部的科学研究与专利所有者更高的内部采用有关.
- 与内部研究相关的候选药物显示出成功开发的可能性增加.
结论:
- 强大的科学基础对于药物候选药物在制药开发中的进展至关重要.
- 内部科学研究促进知识转移,提高内部采用率和成功率.
- 组织对生命科学的专业化可能有缺点,因为集成的内部研究有利于临床开发.
相关概念视频
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Drug Administration and Therapy Phases: Overview
559
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
559
Structure-Activity Relationships and Drug Design
794
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
794
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K


